| Q47786159 | A role for the non-receptor tyrosine kinase ACK1 in TNF-alpha-mediated apoptosis and proliferation in human intestinal epithelial caco-2 cells |
| Q39221586 | Anal Neoplasia in Inflammatory Bowel Disease: Classification Proposal, Epidemiology, Carcinogenesis, and Risk Management Perspectives |
| Q90672631 | Anti-TNF Therapy in Crohn's Disease |
| Q47427964 | Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease. |
| Q52739487 | Association of Gastroesophageal Reflux With Malignancy of the Upper Aerodigestive Tract in Elderly Patients. |
| Q87113559 | Azathioprine May Not be Associated With Development of Colorectal Tumors With Microsatellite Instability in Patients With Inflammatory Bowel Disease |
| Q52644017 | CD38+ M-MDSC expansion characterizes a subset of advanced colorectal cancer patients. |
| Q99237566 | Cancer Risk in Pediatric-Onset Inflammatory Bowel Disease |
| Q55280445 | Carcinoma in the residual rectum of a long-standing Crohn's disease patient following subtotal colectomy: A case report. |
| Q40183418 | Card9-dependent IL-1β regulates IL-22 production from group 3 innate lymphoid cells and promotes colitis-associated cancer |
| Q39016806 | Chemoprevention of colorectal cancer in inflammatory bowel disease |
| Q39290483 | Chemotherapy Tolerance and Oncologic Outcomes in Patients With Colorectal Cancer With and Without Inflammatory Bowel Disease |
| Q48263345 | Chromoendoscopy, Narrow-Band Imaging or White Light Endoscopy for Neoplasia Detection in Inflammatory Bowel Diseases |
| Q47627607 | Clinical characteristics of ulcerative colitis-related colorectal cancer in Chinese patients. |
| Q57818983 | Clinical, Histologic, and Immunophenotypic Features of Serrated Polyps in Patients With Inflammatory Bowel Disease |
| Q38662465 | Colorectal Cancer Screening in Inflammatory Bowel Disease. |
| Q30245054 | Colorectal Cancer and Dysplasia in Inflammatory Bowel Disease: A Review of Disease Epidemiology, Pathophysiology, and Management |
| Q92759068 | Colorectal cancer surveillance in inflammatory bowel disease: Practice guidelines and recent developments |
| Q55411157 | Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells. |
| Q55067205 | Crosstalk between gut microbiota and Sirtuin-3 in colonic inflammation and tumorigenesis. |
| Q39173519 | Culturing human intestinal stem cells for regenerative applications in the treatment of inflammatory bowel disease. |
| Q99561635 | Deficiency of activation-induced cytidine deaminase in a murine model of ulcerative colitis |
| Q59136415 | Defining Early-Onset Colon and Rectal Cancers |
| Q30356090 | Detection and characterization of murine colitis and carcinogenesis by molecularly targeted contrast-enhanced ultrasound |
| Q96304851 | Diagnosis and management of inflammatory bowel disease-associated neoplasia: considerations in the modern era |
| Q38850083 | Diffusion-weighted MRI in Crohn's disease: Current status and recommendations |
| Q49775886 | Early Outcome of Patient with Ulcerative Colitis who Received High Dose of Steroid and Underwent Two Staged Total Proctocolectomy. |
| Q58415823 | Endoscopic Detection of Small Bowel Dysplasia and Adenocarcinoma in Crohn’s Disease: A Prospective Cohort-Study in High-Risk Patients |
| Q64110958 | Endoscopic Submucosal Dissection for Colitis-Associated Dysplasia |
| Q46076755 | Endoscopic Surveillance in Long-standing Colitis |
| Q90055649 | Endoscopic surveillance strategies for dysplasia in ulcerative colitis |
| Q61455101 | Epithelial insulin receptor expression-prognostic relevance in colorectal cancer |
| Q41139928 | Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. |
| Q41140840 | Expression profile of intestinal stem cell markers in colitis-associated carcinogenesis. |
| Q50064077 | Fourier phase based depth-resolved nanoscale nuclear architecture mapping for cancer detection |
| Q40808084 | Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct From Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel Disease |
| Q92653030 | Growth hormone in the tumor microenvironment |
| Q37183586 | Growth hormone is permissive for neoplastic colon growth |
| Q38949434 | Gut Microbiota, Inflammation, and Colorectal Cancer. |
| Q90596633 | Gut microbiota from colorectal cancer patients enhances the progression of intestinal adenoma in Apcmin/+ mice |
| Q38853741 | Higher Risk for Hematological Malignancies in Inflammatory Bowel Disease: A Nationwide Population-based Study in Taiwan |
| Q38754533 | How to Optimize Colon Cancer Surveillance in Inflammatory Bowel Disease Patients |
| Q90239731 | IL-4 and IL-17A Cooperatively Promote Hydrogen Peroxide Production, Oxidative DNA Damage, and Upregulation of Dual Oxidase 2 in Human Colon and Pancreatic Cancer Cells |
| Q92442563 | Imaging Inflammation and Infection in the Gastrointestinal Tract |
| Q93081453 | Infant milk-feeding practices and diagnosed celiac disease and inflammatory bowel disease in offspring: a systematic review |
| Q90206040 | Inflammasomes in Colitis and Colorectal Cancer: Mechanism of Action and Therapies |
| Q47118913 | Inflammatory Bowel Disease Adversely Impacts Colorectal Cancer Surgery Short-term Outcomes and Health-Care Resource Utilization |
| Q26745456 | Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment |
| Q26774592 | Inflammatory bowel disease associated neoplasia: A surgeon's perspective |
| Q48245226 | Inhibition of colon cancer growth by docosahexaenoic acid involves autocrine production of TNFα. |
| Q42683314 | Innate Lymphoid Cells in Intestinal Inflammation |
| Q64230647 | Innate Lymphoid Cells: A Link between the Nervous System and Microbiota in Intestinal Networks |
| Q91976111 | Intervention with α-Ketoglutarate Ameliorates Colitis-Related Colorectal Carcinoma via Modulation of the Gut Microbiome |
| Q39388017 | Intestinal barrier integrity and inflammatory bowel disease: Stem cell-based approaches to regenerate the barrier. |
| Q40248146 | Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis. |
| Q91370950 | Loss of solute carrier family 7 member 2 exacerbates inflammation-associated colon tumorigenesis |
| Q88454720 | Low Incidence of Dysplasia and Colorectal Cancer Observed among Inflammatory Bowel Disease Patients with Prolonged Colonic Diversion |
| Q93045992 | Mixed Adenoneuroendocrine Tumor of the Rectum in an Ulcerative Colitis Patient |
| Q38585910 | Monitoring for Extra-Intestinal Cancers in IBD. |
| Q33666145 | NADPH oxidase 1 supports proliferation of colon cancer cells by modulating reactive oxygen species-dependent signal transduction |
| Q37041213 | Oral health and risk of colorectal cancer: results from three cohort studies and a meta-analysis |
| Q88938416 | Ornithine Decarboxylase in Macrophages Exacerbates Colitis and Promotes Colitis-Associated Colon Carcinogenesis by Impairing M1 Immune Responses |
| Q42279845 | Perspectives on endoscopic surveillance of dysplasia in inflammatory bowel disease: a survey of academic gastroenterologists |
| Q60921182 | Practical guidance for the management of inflammatory bowel disease in patients with cancer. Which treatment? |
| Q49483670 | Pretreatment with probiotic Bifico ameliorates colitis-associated cancer in mice: Transcriptome and gut flora profiling. |
| Q28076161 | Pro-Tumoral Inflammatory Myeloid Cells as Emerging Therapeutic Targets |
| Q87875813 | Prospective study of blood metabolites associated with colorectal cancer risk |
| Q90382197 | Protective Effect of Spirulina platensis Extract against Dextran-Sulfate-Sodium-Induced Ulcerative Colitis in Rats |
| Q43238527 | Protective Role for TWEAK/Fn14 in Regulating Acute Intestinal Inflammation and Colitis-Associated Tumorigenesis |
| Q47769305 | Proximal Disease Extension in Patients With Limited Ulcerative Colitis: A Danish Population-based Inception Cohort. |
| Q50027874 | Risk of malignancy associated with paediatric use of tumour necrosis factor inhibitors |
| Q64283148 | Salidroside regulates the expressions of IL-6 and defensins in LPS-activated intestinal epithelial cells through NF-κB/MAPK and STAT3 pathways |
| Q38603571 | Senescence and cancer: An evolving inflammatory paradox |
| Q99234081 | Sex matters: impact on pathogenesis, presentation and treatment of inflammatory bowel disease |
| Q53187152 | Sildenafil Suppresses Inflammation-Driven Colorectal Cancer in Mice. |
| Q90521142 | Simultaneous Loss of Both Atypical Protein Kinase C Genes in the Intestinal Epithelium Drives Serrated Intestinal Cancer by Impairing Immunosurveillance |
| Q38810116 | Small Bowel Neoplasms and Polyps |
| Q36708344 | Sphingosine-1-phosphate in inflammatory bowel disease and colitis-associated colon cancer: the fat's in the fire |
| Q26745715 | Stem cell-based therapies in inflammatory bowel disease: promises and pitfalls |
| Q57795305 | Strategies for Detecting Colorectal Cancer in Patients with Inflammatory Bowel Disease: A Cochrane Systematic Review and Meta-Analysis |
| Q47966879 | Strategies for detecting colon cancer in patients with inflammatory bowel disease. |
| Q37327836 | Surveillance of IBD Using High Definition Colonoscopes Does Not Miss Adenocarcinoma in Patients with Low-grade Dysplasia. |
| Q39162961 | Systematic review with meta-analysis: use of 5-aminosalicylates and risk of colorectal neoplasia in patients with inflammatory bowel disease. |
| Q99630225 | TLR9 induces colitis-associated colorectal carcinogenesis by regulating NF-κB expression levels |
| Q89866491 | TRIM34 attenuates colon inflammation and tumorigenesis by sustaining barrier integrity |
| Q28354092 | The Changing Phenotype of Inflammatory Bowel Disease |
| Q89706131 | The Complex Interplay Between Inflammatory Bowel Disease and Malignancy |
| Q39253724 | The Protective Role of Type I Interferons in the Gastrointestinal Tract |
| Q30234889 | The Rising Incidence of Younger Patients With Colorectal Cancer: Questions About Screening, Biology, and Treatment |
| Q37580031 | The continuing uncertainty about cancer risk in inflammatory bowel disease |
| Q53621896 | The effects of aminosalicylates or thiopurines on the risk of colorectal cancer in inflammatory bowel disease. |
| Q45055767 | The effects of genetics on pouch neoplasia following restorative proctocolectomy for ulcerative colitis |
| Q59134965 | The phosphatidic acid phosphatase lipin-1 facilitates inflammation-driven colon carcinogenesis |
| Q40515016 | Therapeutic management of inflammatory bowel disease in real-life practice in the current era of anti-TNF agents: analysis of the French administrative health databases 2009-2014. |
| Q38571347 | Therapeutic targeting of inflammation and tryptophan metabolism in colon and gastrointestinal cancer. |
| Q92523556 | Three-Dimensional Nanoscale Nuclear Architecture Mapping of Rectal Biopsies Detects Colorectal Neoplasia in Patients with Inflammatory Bowel Disease |
| Q64235979 | Traditional Chinese medicine for management of recurrent and refractory Crohn disease: A case report |
| Q88899916 | Ulcerative colitis |
| Q36372720 | Use of Methotrexate in the Treatment of Inflammatory Bowel Diseases |
| Q96431025 | Which long noncoding RNAs and circular RNAs contribute to inflammatory bowel disease? |
| Q48501972 | YAP/TAZ-Dependent Reprogramming of Colonic Epithelium Links ECM Remodeling to Tissue Regeneration |